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Abstract
In this study we present a rare case of peripheral desmoplastic ameloblastoma and discuss its clinical features, 
histopathology, and inmunoshistochemical profile.
This article reports a new case of this unusual neoplasm in a 66 year-old woman in which the main complaint was 
an asymptomatic swelling located in the right body of mandible.  Histopathological findings were similar to the 
two previously reported cases of this tumor. Positive immunohistochemical stain for laminin V and type IV col-
lagen suggests an inductive effect of the epithelium over the stroma while the low index of p53 protein and Ki-67 
expression in epithelium and stromal cells, as well as CD138 uniform positive-stain in epithelial cells, support the 
benign biological behavior of this lesion. Including this new case, currently there are only three reports of this rare 
neoplasm. Reports of new cases of peripheral desmoplastic ameloblastoma are necessary for a better understand-
ing of the origin and behavior of this particular subtype of ameloblastoma.
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Introduction
Peripheral odontogenic tumors (POT) are uncommon 
lesions, accounting from 1.24% to 3.4% of all odon-
togenic tumors (1,2). According to previous reports, the 
most frequent POT are peripheral odontogenic fibroma 
(POF) and peripheral ameloblastoma (PA) with 40% 
and 36% respectively (1). Contrary to  POF its intraos-
seous counterpart (central odontogenic fibroma) has a 
higher potential of aggressiveness. On the other hand, it 
is well recognized the high rate of recurrence observed 
in central solid types of ameloblastomas, which far 
exceeds what has been reported for PA. Desmoplastic 
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ameloblastoma (DA) was initially defined as a central 
lesion but recently, two cases of peripheral desmoplastic 
ameloblastoma (PDA) were reported (3,4). In this study 
we present an additional case of this unusual neoplasm, 
and discuss its clinical features, histopathology, and in-
munoshistochemical profile.
Case Report
A 66-year-old woman presented for diagnosis and man-
agement of an asymptomatic swelling located in the right 
body of mandible. Clinical examination revealed an exo-
phytic mass of 2 cm of diameter, firm to palpation. An 
excisional biopsy was perfomed and the specimen was 
sent to histopathological study. No evidence of bone re-
sorption in the area was observed during surgery. 
Five μm sections of paraffin-embedded tissue were 
stained with H&E stain and immunohistochemistry 
was performed using avidin-biotin complex technique. 
(Table 1) shows antibodies, dilutions and sources of an-
tibodies used in this case.
Microscopical examination disclosed a lesion constitut-
ed by irregular islands of odontogenic epithelium em-
bedded in a collagenized stroma. Epithelial islands were 
arranged in nest, narrow cords and more solid sheets of 
odontogenic epithelium (Fig. 1a). Columnar cells with 
reverse polarization were not a predominant feature. 
Some islands were hypercellular with central squamous 
metaplasia and fusiform cells (Fig. 1b). Multiple micro-
cystic degeneration was observed (Fig. 1a). Stroma was 
densely collagenized but myxoid changes were found 
adjacent to epithelial islands.
Antibody Source/clone Dilution 
Cytokeratin cocktail 
CK1 
CK5 
CK6 
CK8 
CK10 
CK13 
CK14 
Ck16 
CK18 
CK19 
CK20 
Vimentin 
ĮSMA 
p53 
Ki-67 
S-100 
CD138 
Collagen IV 
Laminin 
Dako™, AE1/AE3 
Novocastra™,34ȕB4 
Novocastra™,XM26 
Novocastra™,LHK6B 
Dako™,OV-TL12/30 
Dako™, DE-K-10 
Novocastra™,KS-1A3 
Novocastra™,NCL-L-LL002
Novocastra™,LL025 
Dako™,DC10 
Dako™,RCK108 
Dako™,Ks20.8 
Dako™,Vim 3B4 
Dako™,1A4 
Dako™,DO-7 
Dako™,MIB-1 
Dako™ 
Dako™,MI15 
Dako™,CIV 22 
Laminin 
1:500 
1:200 
1:400 
1:400 
1:400 
1:200 
1.400 
1:400 
1:400 
1:400 
1:400 
1:200 
1:200 
1:400 
1:200 
1:100 
1:12,000 
1:100 
1:200 
1:200 
 
Table 1. Antibodies, sources, clones and dilutions applied in present case.
Fig. 1.  Photomicrographs showing (a) neoplastic odontogenic epithelium associated to a densely collagenized stroma with multiple microcystic 
degeneration, (b) note the central squamous metaplasia (H&E stain, original magnification x200 and x400). 
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Odontogenic epithelial islands were positive for cytok-
eratin cocktail AE1/AE3, 34βE12 and CD-138 (syn-
decan-1) (Fig. 2a). CK5 was positive in basal and su-
prabasal cells, while some suprabasal and central cells 
were positive to CK14 (Fig. 2b). Focal stain for CK13 
and S-100 protein were observed in squamous central 
cells. Cytokeratins 1, 6, 8, 10, 16, 18, 19 and 20 were not 
expressed. Stromal cells were positive for vimentin; an-
tibodies for muscle differentiation (HHF-35 and SMA), 
Bcl-2 and p21 were also negative. p53 and Ki-67 index 
were lower than 1% in epithelial islands and negative 
in stromal cells. On the other hand, basal membrane of 
epithelial tissue was intensely positive for laminin V 
and type IV collagen (Fig. 3).
After four year of follow-up there are no signs of recur-
rence.
Fig. 2. (a) High expression of syndecan-1 (CD 138) in the ameloblastic epithelium, (b) Positive stain in suprabasal and central epithelial cells for 
CK14 in PDA (CD138 and CK14, original magnification x400).
Fig. 3. Expression of Laminin V (a) and type IV Collagen (b) antibodies in basal lamina of PDA (original magnification, x400).
Discussion 
Since its original description by Eversole et al. (5) DA 
is considered a rare variant of Central Ameloblastoma 
(CA). CA represents a frequent odontogenic tumor ac-
counting for 11-60% off all central odontogenic tumors 
(6,7) and DA accounts for 5.3% of all CA (8). To date, 
145 cases of DA have been reported in English litera-
ture; (9) of these, only two can be considered as periph-
eral (3,4). It is well known that there are histological and 
biological behavioral differences among DA and the 
other types of CA. For example, DA poses a lower re-
currence rate as compared to CA. The histological find-
ings in our case are in accordance with previous reports 
of PDA and DA (3,10,11). Sivapathasundharam et al. (9) 
suggest that epithelial changes can be related to pres-
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sure of stroma on epithelial tissue or may be  associated 
to changes in maturation of a preexistent CA. However, 
Kishino et al. (8) and Kawai et al. (12) suggest that DA 
derives from periodontal ligament, and based their ob-
servation in the presence of oxytalan fibers in stroma of 
this neoplasm. In our case, the lack of continuity of the 
lesion with surface epithelium and the negative stain of 
PDA for CK19 in this case is in accordance with the ob-
servations of  Philipsen et al. (11), who suggest that the 
origin of this neoplasm can be remnants of dental lam-
ina located in gingival tissues. Immunohistochemical 
expression of CK5 in basal/suprabasal cells and CK14 
in suprabasal/central cells in the present case offer evi-
dence of maturation of the epithelial component; low 
index of p53 protein and Ki-67 expression in epithelium 
and stromal cells of PDA, as well as CD138 uniform 
positive-stain in epithelial cells, support the benign bio-
logical behavior of the lesion, as has been reported pre-
viously in their intraosseus counterpart. (13) High ex-
pression of syndecan-1 in DA could be associated with 
a better cell–cell and cell–extracellular matrix adhesion 
in epithelial ameloblastic zones (islands), suggesting a 
less aggressive and invasive behavior and could explain, 
to some degree, the unique clinicopathological features 
of this slow growing lesion, which in turn, may favor 
the presence of desmoplasia (14).
Another finding of interest in our case was the positive 
stain for laminin V and type IV collagen, suggesting an 
inductive effect of the epithelium over the fibrous stro-
ma, which may result in a duplicated basal lamina; this 
findings support the observations of  Lam et al. (15), 
who found inductive effects expressed in the form of 
deposits of an acellular eosinophilic matrix associated 
to epithelial islands in five of eight cases of DA. Perie-
pithelial myxoid changes and the mechanism of desmo-
plasia are far from being understood (11).
Including this new case, currently there are only three 
reports of PDA. However, reports of new cases of PDA 
are necessary for a better understanding of the origin 
and biological behavior of this particular lesion.
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